He is a graduate of Princeton University (BA Chemistry) and the University of Pennsylvania (Ph.D. Biological Chemistry). Dr. Olah joined the Department of Drug Metabolism at Merck Research Laboratories in West Point, PA and helped establish the first LCMS-based Bioanalytical group under the late Dr. John D. Gilbert. He moved to the DuPont Pharmaceuticals Company in 2000. Following the purchase of DuPont Pharmaceuticals by Bristol-Myers Squibb in 2001, he was appointed the Director of Bioanalytical Research. Dr. Olah has over 95 publications and has presented at numerous international universities and conferences throughout his career.
This page has been accessed
61
times since 9/15 /96 .
Last Updated 2/21/2017